Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Share-based Compensation (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Share-based Compensation for 3 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 68.8% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, down 89.47% year-over-year, with the annual reading at $13.8 million for FY2025, 89.47% down from the prior year.
  • Share-based Compensation hit $1.1 million in Q4 2025 for Guardian Pharmacy Services, down from $4.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $122.4 million in Q3 2024 to a low of -$22.7 million in Q4 2023.
  • Historically, Share-based Compensation has averaged $13.6 million across 3 years, with a median of $4.0 million in 2025.
  • Biggest YoY gain for Share-based Compensation was 1734.93% in 2025; the steepest drop was 96.44% in 2025.
  • Year by year, Share-based Compensation stood at -$22.7 million in 2023, then soared by 115.23% to $3.5 million in 2024, then tumbled by 68.8% to $1.1 million in 2025.
  • Business Quant data shows Share-based Compensation for GRDN at $1.1 million in Q4 2025, $4.4 million in Q3 2025, and $4.4 million in Q2 2025.